DE69632909D1 - Verhinderung oder behandlung von schäden des verdauungstraktes auf grund von chemotherapie und bestrahlung - Google Patents

Verhinderung oder behandlung von schäden des verdauungstraktes auf grund von chemotherapie und bestrahlung

Info

Publication number
DE69632909D1
DE69632909D1 DE69632909T DE69632909T DE69632909D1 DE 69632909 D1 DE69632909 D1 DE 69632909D1 DE 69632909 T DE69632909 T DE 69632909T DE 69632909 T DE69632909 T DE 69632909T DE 69632909 D1 DE69632909 D1 DE 69632909D1
Authority
DE
Germany
Prior art keywords
damage
chemotherapy
radiation
preventing
treating digestive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69632909T
Other languages
English (en)
Other versions
DE69632909T2 (de
Inventor
Christine Read
Stanley Howarth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Biopharma AU Ltd
Original Assignee
Gropep Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gropep Ltd filed Critical Gropep Ltd
Publication of DE69632909D1 publication Critical patent/DE69632909D1/de
Application granted granted Critical
Publication of DE69632909T2 publication Critical patent/DE69632909T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69632909T 1995-05-02 1996-05-02 Verhinderung oder behandlung von schäden des verdauungstraktes auf grund von chemotherapie und bestrahlung Expired - Fee Related DE69632909T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN2712A AUPN271295A0 (en) 1995-05-02 1995-05-02 Method of treatment
AUPN271295 1995-05-02
PCT/AU1996/000253 WO1996034614A1 (en) 1995-05-02 1996-05-02 Method of preventing or treating alimentary tract damage due to chemotherapy or radiation

Publications (2)

Publication Number Publication Date
DE69632909D1 true DE69632909D1 (de) 2004-08-19
DE69632909T2 DE69632909T2 (de) 2004-12-09

Family

ID=3787062

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69632909T Expired - Fee Related DE69632909T2 (de) 1995-05-02 1996-05-02 Verhinderung oder behandlung von schäden des verdauungstraktes auf grund von chemotherapie und bestrahlung

Country Status (8)

Country Link
US (1) US6183784B1 (de)
EP (1) EP0825868B1 (de)
JP (2) JP2000514399A (de)
AU (1) AUPN271295A0 (de)
CA (1) CA2213302C (de)
DE (1) DE69632909T2 (de)
NZ (1) NZ306349A (de)
WO (1) WO1996034614A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0917467B1 (de) * 1996-07-02 2003-02-19 Pharmaproducts UK Limited Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
GB9619660D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
GB9619634D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
ES2139525B1 (es) * 1997-11-17 2000-10-16 Sanchez Pedro Cuevas Empleo de derivados del lactosuero como citoprotectores y cicatrizantes.
CA2371241A1 (en) * 1999-04-26 2000-11-02 Stem Cell Pharmaceuticals, Inc. Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
US20020099008A1 (en) * 1999-04-26 2002-07-25 Daniel R. Twardzik Method for stimulating hematopoiesis using tgf-alpha
EP1068871A1 (de) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Neue Methoden und Medikamente zur Behandlung von Infektionen welche auf einen mikrobielle Biofilm beruhen
WO2001024812A1 (en) * 1999-10-06 2001-04-12 N.V. Nutricia USE OF TRANSFORMING GROWTH FACTOR β AND GROWTH FACTORS IN THE TREATMENT AND PREVENTION OF DISEASES OF THE INTESTINAL MUCOSA
US20020061304A1 (en) 2000-03-20 2002-05-23 Pfizer Products Inc. & Osi Pharmaceuticals, Inc. Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
AUPQ878600A0 (en) * 2000-07-13 2000-08-03 Gropep Pty Ltd Compositions and methods for the treatment of intact skin
AU2002236477A1 (en) 2000-11-21 2002-06-03 The Texas A & M University System Fgf-affinity chromatography
US20030040475A1 (en) * 2001-01-16 2003-02-27 Yasuhiro Toba Agents for improving lipid metabolism and reducing high blood pressure
FR2827290B1 (fr) * 2001-07-13 2004-07-09 Pierre Jouan Biotechnologies Sa Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
US6906038B2 (en) * 2001-08-29 2005-06-14 Abbott Laboratories Methods for alleviating mucositis
JP2005507919A (ja) * 2001-10-26 2005-03-24 ユニヴァーシティ・テクノロジーズ・インターナショナル・インコーポレーテッド 泌尿生殖器経路の病原感染を阻害するためのｅｇｆの使用
GB0209384D0 (en) 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition
AUPS282002A0 (en) * 2002-06-06 2002-06-27 Gropep Limited Metalloproteinase inhibitors
ATE407574T2 (de) * 2003-09-12 2008-09-15 Nestec Sa Fraktionen und zubereitungen aus milch zur behandlung und / oder vorbeugung cox-2 vermittelter krankheiten
EP1675480B1 (de) 2003-10-16 2018-06-13 Nestec S.A. Nahrhafte zusammensetzung gegen die nebenwirkungen von chemotherapie oder strahlentherapie
AU2006335883B2 (en) * 2006-01-20 2011-04-28 Morinaga Milk Industry Co., Ltd. Pharmaceutical composition, food or drink, or feed for intestinal disease
JP2007302640A (ja) * 2006-05-15 2007-11-22 Natl Inst Of Radiological Sciences 抗放射線被ばく障害剤
EP2049135A4 (de) * 2006-06-22 2009-12-30 Agennix Inc Lactoferrin als radioprotektives mittel
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
CN105876780A (zh) * 2008-09-19 2016-08-24 雀巢产品技术援助有限公司 抗癌治疗中的免疫系统营养支持
CN102215837B (zh) 2008-09-19 2014-04-30 雀巢产品技术援助有限公司 预防和/或减轻癌性肿瘤的骨髓毒性的营养支持
JP2011051914A (ja) * 2009-08-31 2011-03-17 Obihiro Univ Of Agriculture & Veterinary Medicine 低温殺菌処理ホエータンパク濃縮物を含む腸管炎症抑制剤
US20220202914A1 (en) * 2019-05-06 2022-06-30 Synthetic Biologics, Inc. Alkaline phosphate-based oncology treatments
US11573179B2 (en) * 2019-08-22 2023-02-07 Applikate Technologies Llc Tissue processing

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
US5102870A (en) * 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
CA2086681C (en) * 1990-07-13 2004-01-06 Francis J. Ballard Growth promoting agent derived from milk
DE69133218T2 (de) * 1990-09-25 2004-02-12 Asahi Medical Co. Ltd. Methode und filtersystem zur entfernung von leukozyten
ATE194169T1 (de) * 1990-11-16 2000-07-15 Celtrix Pharma Beta-type ähnlicher transformierender wachstumfaktor
JPH06506939A (ja) * 1991-04-12 1994-08-04 クリエイティブ　バイオモレキュルズ　インコーポレイテッド 血小板由来の成長因子に依る消化管潰瘍の治療方法
EP0527283B1 (de) * 1991-08-12 1997-11-26 Societe Des Produits Nestle S.A. Nahrungsmittelzusammensetzung
NZ260309A (en) 1992-06-08 1997-07-27 Pharmacia Ab Substituted For K Use of 1gf-2 for prevention or treatment of nutritional or gastrointestinal disorders and promoting neonatal growth
KR100390340B1 (ko) * 1993-03-26 2003-09-26 암겐 인코포레이티드 케라티노사이트성장인자산물을함유하는제약학적조성물
AU6847894A (en) 1993-06-23 1995-01-17 Viable Bioproducts Ltd. Method for the improvement of wound healing and compositions therefor
AUPM534794A0 (en) * 1994-04-28 1994-05-19 Gropep Pty Ltd Modified milk growth factor

Also Published As

Publication number Publication date
EP0825868A4 (de) 2001-02-21
JP2008143909A (ja) 2008-06-26
CA2213302A1 (en) 1996-11-07
NZ306349A (en) 2000-06-23
WO1996034614A1 (en) 1996-11-07
CA2213302C (en) 2002-09-24
AUPN271295A0 (en) 1995-05-25
US6183784B1 (en) 2001-02-06
JP2000514399A (ja) 2000-10-31
EP0825868A1 (de) 1998-03-04
EP0825868B1 (de) 2004-07-14
DE69632909T2 (de) 2004-12-09

Similar Documents

Publication Publication Date Title
DE69632909D1 (de) Verhinderung oder behandlung von schäden des verdauungstraktes auf grund von chemotherapie und bestrahlung
NO971015L (no) Forbindelser og metoder for behandling av cancer
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
DE69500089D1 (de) Behandlung von Geflügel
DE69309704D1 (de) Datenverarbeitungssystem und betriebssystem
DE69434511D1 (de) Botulinumtoxin zur Behandlung von Dystonie
ATE104380T1 (de) Sauerstoffdelignifizierung und enzymatische behandlung.
NO975832D0 (no) Fremgangsmåter for forhindring eller behandling av allergier
DE69424640D1 (de) Filmbehandlungsmethode und System
DE69817862D1 (de) Naringin und naringenin als mittel zur vorbeugung oder behandlung von leber-erkrankungen
NO971900D0 (no) Blandinger og behandling av multippel sklerose
DK73891D0 (da) Enzymbehandling
DE69427485D1 (de) Verbindungen, zubereitungen und behandlung von allergien und entzündungen
DE69429101D1 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
DE69810499T2 (de) Behandlung von industriegeweben
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
BR9304004A (pt) Método de tratamento de arrozal
DE69306335D1 (de) Prevention und Behandlung von Atherosclerosis
DE69132054D1 (de) Behandlung von windelausschlag
DE3853841D1 (de) Nichtfleckenbildende und wenigfleckenbildende Ozon-Schutzmittel.
DE69520268T2 (de) Behandlung von Legierungen und danach hergestellte Gegenstände
NO961113D0 (no) Behandling og forebyggelse av prostatakreft
NO985068L (no) Vaksiner for behandling av lymfom og leukemi
DE69429259D1 (de) Behandlung von futtern und fasergut

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES BIOPHARMA AU LTD., ADELAIDE, AU

8339 Ceased/non-payment of the annual fee